Managing acute hypertension: cost considerations.
The cost-effectiveness of nifedipine for the control of acute hypertension is analyzed. The study compares routine hospital utilization of a set of patients who were administered nifedipine (the experimental group) with a set of patients who were given nitroprusside (the control group). The experimental group consists of a set of 32 patients who presented to the emergency department with acute hypertension and were treated with nifedipine. The control group is a set of 14 patients who presented with acute hypertension to the emergency departments of two other hospitals. Both experimental and control groups were seen and treated in 1983 and 1984. The patients in the control group were matched/paired with the experimental group patients. Hospital utilization was measured at four times: one, two, three, and four days after admission. For each time, utilization is classified as intensive, intermediate, or routine. In addition, intensive care is further classified according to nursing/patient ratios. Differences in both utilization levels and total costs are compared for the matched control and experimental groups.
D000208:Acute Disease; D002140:California; D003362:Cost-Benefit Analysis; D004363:Drug Utilization / Q000191:economics; D004630:Emergencies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D007362:Intensive Care Units / Q000191:economics; D009543:Nifedipine / Q000627:therapeutic use*; D009599:Nitroprusside / Q000627:therapeutic use; D010607:Pharmacy Service, Hospital / Q000191:economics*
D009599:Nitroprusside; D009543:Nifedipine